MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Eye, Ocular, Optometry, Ophthalmology, Vision Health Companies
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)
Finance & Acquisitions: Apellis
Parents
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)
Children
2011: Amt: 1.7M Round: Series A (2011)
2023: Apellis Announces Corporate Restructuring to Drive Growth of SYFOVRE® (pegcetacoplan injection) and EMPAVELI® (pegcetacoplan), Positioning Company for Long-Term Success
2024: Apellis Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
2025: Apellis Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation
2026: Biogen Completes Acquisition of Apellis Pharmaceuticals
Apellis Pharmaceuticals Stock Quote: APLS Stock News, Quotes, Analysis
Apellis Pharmaceuticals, Inc. (APLS) Analyst Research
Investor(s) Pegasus Capital Advisors, HealthCare Ventures, MASA Life Science Ventures
www.crunchbase.com
Jumps
*Key People: Apellis
Organization & Developments: Apellis